Hims & Hers Health Inc

Hims & Hers CEO Andrew Dudum defended the telehealth company amid a Federal Trade Commission lawsuit over its…
Read More...

Shares of telehealth company Hims & Hers Health fell sharply Wednesday after the Federal Trade Commission sued…
Read More...

Michael Siluk | UCG | Universal Images Group | Getty ImagesLosing weight with GLP-1 drugs is only half the battle.…
Read More...

Mammoth Brands wants to take on traditional consumer packaged goods companies, armed with a portfolio of disruptors…
Read More...

Piotr Swat | Lightrocket | Getty ImagesTelehealth company Hims & Hers' stock plummeted on Tuesday after posting a…
Read More...

Amazon GLP-1 treatmentSource: Amazon Inc. Amazon is pushing deeper into the booming weight loss market, unveiling…
Read More...

Piotr Swat | Lightrocket | Getty ImagesAs its high-margin compounded GLP-1 business evolves, Hims & Hers Health…
Read More...

The U.S. Food and Drug Administration has approved Eli Lilly's GLP-1 pill, the company said, a major milestone for…
Read More...

Novo Nordisk is investing 432 million euros ($506 million) in a facility in Ireland as it expands its production…
Read More...

An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York on March 28, 2024.Shelby…
Read More...